Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
300015 Aier Eye Hospital Group
28.930
-0.120-0.41%
YOY
Do not show
Hide blank lines
(Q9)2022/09/30(Q6)2022/06/30(Q3)2022/03/31(FY)2021/12/31
Per Share Indicator
Net Asset Per Share
11.03% 2.2624 21.02% 2.266 -12.04% 2.1941 -12.50% 2.092
Basic Earning Per Share
-9.60% 0.3371 16.77% 0.2416 -2.64% 0.1143 2.43% 0.4334
Diluted  Earning Per Share
-9.60% 0.3371 16.94% 0.2416 -2.98% 0.1139 2.43% 0.4334
Earning Per Share
-11.39% 0.3284 15.41% 0.2382 -3.83% 0.1129 2.77% 0.4298
Diluted Earning Per Share(TTM)
-7.56% 0.373 15.17% 0.4609 -12.24% 0.4532 2.77% 0.4298
Capital Surplus Funds Per Share
37.78% 0.5631 2.86% 0.4132 -29.42% 0.4038 -29.03% 0.4093
Undivided Profit Per Share
9.23% 0.8391 71.16% 1.0338 15.45% 0.9108 19.03% 0.7993
Operating Cash Flow Per Share
-7.11% 0.5577 20.75% 0.4271 6.28% 0.1912 -6.88% 0.7555
Enterprise FCF Per Share
-38.52% 0.305 -26.75% 0.3004 69.25% 0.0743 20.38% 0.5293
Shareholder FCF Per Share
-56.30% 0.2284 -53.40% 0.2046 -78.51% 0.024 58.62% 0.5306
EBIT Per Share
-15.70% 0.4466 11.47% 0.3314 -7.30% 0.169 3.37% 0.6019
Profitability
ROE Weighted
3.18% 19.470% 1.97% 10.880% 10.02% 5.270% -4.19% 20.580%
ROE
-20.17% 14.518% -4.65% 10.512% 9.34% 5.148% 17.43% 20.543%
ROA
-9.19% 10.558% -5.32% 6.374% 0.22% 3.137% -3.45% 13.212%
ROIC
-6.04% 15.197% 3.29% 9.462% 13.19% 4.813% 7.89% 18.406%
Net Profit Ratio
5.27% 19.715% 4.89% 17.603% 7.33% 16.623% 4.49% 16.465%
Gross Income Ratio
-0.75% 51.913% 1.20% 49.324% -0.67% 46.996% 1.76% 51.923%
EBIT To Total Operating Revenue
-0.59% 24.554% 1.31% 22.162% 2.43% 21.917% 7.68% 21.692%
Period Costs Rate
0.31% 24.981% 2.82% 24.769% -2.04% 24.665% 7.95% 24.890%
Operating Expense Rate
1.00% 9.641% 1.59% 9.702% -1.24% 9.374% 7.74% 9.645%
Admini Expense Rate
5.57% 13.939% 13.06% 13.677% -1.12% 13.344% 9.07% 13.051%
Financial Expense Rate
-118.77% -0.149% -101.53% -0.016% -32.20% 0.576% -6.45% 0.710%
Recurrent Net Profit
15.10% 2.5B 12.65% 1.38B 22.49% 623.05M 30.59% 2.78B
Operating Profit Ratio
0.01% 26.094% 0.66% 23.831% -2.92% 21.784% 3.76% 23.292%
EBIT
11.88% 3.2B 11.79% 1.8B 21.60% 913.62M 35.59% 3.25B
Solvency
Current Ratio
29.37% 1.7301 -8.21% 1.1425 -33.70% 1.1521 -32.10% 1.1497
Quick Ratio
31.69% 1.6418 -8.72% 1.053 -33.70% 1.0671 -31.47% 1.0586
Debt Equity Ratio
-31.75% 56.682% -19.95% 74.523% 1.88% 73.758% 71.57% 78.738%
Interest Cover(T)
-- -- -- -- 51.09% 38.0646 -53.38% 30.6251
Shareholders Equity Without Minority Interests To Total Liabilities
49.95% 166.881% 26.06% 125.450% -1.83% 125.152% -41.71% 117.505%
Shareholders Equity Without Minority Interests To Interest Bear Debt
110.60% 860.4304% 73.98% 640.0695% 28.90% 561.2715% 3.38% 474.3382%
Long Debt To Working Capital
-69.14% 0.6606 18.56% 3.5205 126.40% 3.8017 430.19% 3.5652
Growth Ability
Average Net Profit YOY Past Five Year
-0.66% 33.848% 21.13% 34.436% 678.54% 108.927% -7.70% 32.221%
Sustainable Grow Rate
3.23% 22.751% 0.84% 12.619% 11.02% 6.127% -1.05% 18.067%
Operating Capacity
Operating Cycle(D/T)
-2.46% 58.077 -3.38% 60.9023 -9.74% 55.5361 -6.43% 61.7869
Inventory Turnover Days(D/T)
-0.12% 24.7462 2.74% 25.3027 -5.33% 22.023 -0.75% 26.6033
Accounts Receivable Turnover Days(D/T)
-4.13% 33.3309 -7.30% 35.5996 -12.42% 33.5131 -10.32% 35.1836
Inventory turnover Rate(T)
0.12% 10.9108 -2.66% 7.1139 5.62% 4.0866 0.76% 13.5321
Accounts Receivable Turnover Rate(T)
4.31% 8.1006 7.88% 5.0562 14.18% 2.6855 11.50% 10.2321
Current Assets Turnover Rate(T)
-19.60% 1.4056 -2.86% 1.1056 -0.56% 0.5899 -4.80% 2.3448
Total Assets Turnover Rate(T)
-7.29% 0.5355 -2.84% 0.3621 0.86% 0.1887 -14.03% 0.7466
Fixed Assets Turnover Rate(T)
-- -- -21.89% 2.7134 -- -- 8.53% 6.6948
Equity Turnover Rate(T)
-14.73% 0.9476 -6.59% 0.6872 3.15% 0.3598 -2.13% 1.4176
Cash Position
Free Cash Flow
-18.38% 2.19B -26.53% 1.63B 122.00% 401.52M 57.89% 2.86B
Net Profit Cash Cover
4.07% 155.544% 4.64% 162.253% 9.37% 149.159% -7.17% 165.355%
Operating Revenue Cash Cover
-0.34% 98.641% 1.42% 98.189% 0.86% 98.066% 1.05% 99.579%
Operating Cash In To Assets
1.58% 16.422% 6.64% 10.342% 18.43% 4.679% -16.61% 20.326%
Dividend Ability
Dividend Per Share
-- -- -- -- -- -- -19.29% 0.1197
Dividend Cover(T)
-- -- -- -- -- -- 28.44% 3.5814
Cash Dividend Cover(T)
-- -- -- -- -- -- 16.40% 6.2955
Dividend Paid Ratio
-- -- -- -- -- -- -22.14% 27.922%
Retained Earning Ratio
0.00% 100.000% 0.00% 100.000% 0.00% 100.000% 12.38% 72.078%
Capital Structure
Debt Assets Ratio
-20.26% 36.176% -11.43% 42.701% 1.08% 42.449% 40.04% 44.052%
Current Assets To Total Assets
19.84% 42.223% -6.53% 32.490% -4.93% 30.989% -9.09% 33.024%
Non Current Assets To Total Assets
-10.79% 57.777% 3.48% 67.510% 2.38% 69.011% 5.19% 66.976%
Fix Assets Ratio
-- -- 28.86% 13.030% -- -- -19.17% 10.910%
Interest Bearing Debt To Total Capital
-46.31% 9.905% -36.64% 12.745% -19.24% 14.124% -2.72% 16.322%
Yield Quality
Invest Revenue From Associates To Total Profit
96.00% 0.000% 93.10% 0.000% 92.86% 0.000% 50.00% -0.002%
Net Income From Value Changes To Total Profit
-230.27% -1.222% -7.21% -1.310% -130.41% -1.146% -4.21% -9.762%
Recurrent Net Profit To Net Profit
-2.85% 97.298% -2.66% 96.856% -3.87% 89.914% -0.75% 112.665%
Dupont Analysis
Equity Multipler_DuPont
-8.03% 1.770% -3.85% 1.898% 2.25% 1.907% 13.84% 1.899%
Net Profit of Parent Company OwnersTo Net Profit_DuPont
-0.70% 91.604% -0.01% 90.480% -1.00% 88.118% 2.44% 94.066%
Net Profit To Total Operating Revenue_DuPont
5.27% 19.715% 4.89% 17.603% 7.33% 16.623% 4.49% 16.465%
Net Profit To Total Profit_DuPont
1.87% 79.806% 2.24% 78.114% 3.34% 77.891% -1.22% 78.466%
Total Profit To EBIT_DuPont
3.96% 100.608% 1.26% 101.683% 1.40% 97.373% -1.77% 96.735%
EBIT To Total Operating Revenue_DuPont
-0.59% 24.554% 1.31% 22.162% 2.43% 21.917% 7.68% 21.692%
Currency Unit
CNYCNYCNYCNY

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
The company is a well-known global chain of ophthalmic medical institutions, IPO listed medical institutions (stock code: 300015, selected into the Shanghai and Shenzhen 300th index in 2015). By 2019, more than 300 professional eye hospitals had been established in 30 provinces, cities and autonomous regions of Chinese mainland, covering more than 70 percent of the country's health insurance population and more than 6.5 million outpatients annually. In addition, there are more than 80 eye hospitals in the United States, Europe and Hong Kong, China. As a professional ophthalmology chain medical institution, the company is mainly engaged in the diagnosis and treatment of all kinds of ophthalmic diseases, surgical services and medical optometry and optometry. At present, the medical network has spread throughout Chinese mainland, Hong Kong, China, Europe, the United States and Southeast Asia. It has established the strategic pattern of global development. As a professional ophthalmology chain medical institution, the company is mainly engaged in the diagnosis and treatment of all kinds of ophthalmic diseases, surgical services and medical optometry. The honors include Ayre Ophthalmology won the top 10 of China's "most respected listed companies by investors", Ayre Ophthalmology won the Best Sustainable Investment value Award, the most influential listed Company Leader Award, Gold Secret Award, Ayre Ophthalmology won the Best shareholder return Award of Chinese listed companies in 2017, and so on.
CEO: --
Market: --
Listing Date: 10/30/2009
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist